Multisystem inflammatory syndrome in children (MIS-C), United States, 2023-2024.
Where this comes from
- Record sourced from PubMed, PMID 42037548.
- Also identified by DOI 10.1093/cid/ciag259.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Multisystem inflammatory syndrome in children (MIS-C) is rare following SARS-CoV-2 infection, but sporadic cases continue to be reported. This analysis of cases from 2023-2024 shows little change in clinical presentation between years. Among vaccine age-eligible children, 99% of cases occurred in children who were not up-to-date with COVID-19 vaccination.